As airports become stretched to capacity and calls mount for new runways and terminals, a computer scientist in Greece has designed a system that could ensure as many seats as possible are filled on each flight and no one is left stranded at check-in.    If you're one of those people who has logged numerous free miles giving up your seat and getting a free ticket in return, that could be bad news.

Montana State University scientists concerned about lethal mold infections have found a gene that regulates the mold's resistance to drugs.

The gene, called srbA, allows molds to thrive during infections even when inflammation reduces its oxygen supply, said Robert Cramer, senior author of a paper published in the Nov. 7 issue of PLoS Pathogens. When the gene is removed, the mold becomes much more vulnerable to lack of oxygen and can no longer grow to cause disease.

If you're a yogurt consumer like myself, you've probably noticed the aisle flooded with signs for probiotic yogurt, probiotic shots and even probiotic candy bars (hey, it's true!)  While staying away from these items for some time I thought I'd now try to figure out the reality behind these and put the hype to rest.

Apparently, probiotics have been used for centuries as natural components in health-promoting foods and upon transportation to the United States, they have sparked a huge growth in the yogurt industry for their claims of increased immune response as well as sufficient promotion toward digestive health.

I love to travel. Exploring new places, seeing new sights and eating new types of food are among the top greatest things. But traveling has some serious consequences. Not only do you have to deal with the circus that ensues when you try to get on the plane, and must sit on a plane for however many hours that it takes to get to your destination, but then you have to spend the next significant chunk of your

precious travel time adjusting to the time. What if you could skip the recuperation time and avoid your jet lag? According to a new study published in Minerva Cardioangiologica, you can by taking pine bark extract.

BUFFALO GROVE, Illinois, November 7 /PRNewswire/ --

Eagle Test Systems, Inc. (Nasdaq: EGLT), a provider of automated test equipment solutions for high-performance analog, mixed-signal and radio frequency (RF) semiconductors, announced today that, at a special meeting of its stockholders, the holders of a majority of the outstanding shares of common stock of Eagle Test adopted the previously announced merger agreement among Eagle Test, Teradyne, Inc. (Teradyne) and Turin Acquisition Corp., a Delaware corporation and a wholly owned subsidiary of Teradyne.

NEW YORK, November 7 /PRNewswire/ --

- NRG CEO to Advocate Transition to Low Carbon-Emitting Society;Joins Former U.S. Secretary of State Albright as a Featured Speaker

At the second annual Platts Lecture, Sense and Sustainability: What Strategies Will Really Work to Create a New Energy Future? NRG Energy President and CEO David Crane is expected to call on the energy industry to smooth its transition to a low-carbon economy. The lecture will be held December 3 at Deutsche Bank headquarters in New York City in conjunction with the 10th annual Platts Global Energy Awards.

ZURICH, Switzerland, November 7 /PRNewswire/ --

Matterhorn Capital Ltd, the US$300 million Swiss industrial and technology investment company, announced today that co-founder, Jonathan H. Holley, has sold his stake in the company to a group of existing shareholders. No transaction details were disclosed.

Mr. Holley had previously notified the Board of Directors of his intention to sell his stake upon his appointment as Chief Executive Officer of Dubai Group-Tatweer Fund Management Company in the United Arab Emirates.

TOKYO, November 7 /PRNewswire/ --

- Large, International REACH Registry Also Shows Many Patients With Atrial Fibrillation are Undertreated With Antiplatelet and Anticoagulant Therapies

A significant portion of patients with atherothrombosis also have atrial fibrillation (AF), greatly increasing their risk for cardiovascular death, heart attack and stroke, according to new findings from the large, international REACH registry published today in the American Heart Journal.(1) The findings also showed that standard treatments including anticoagulant and antiplatelet therapies are underused in AF patients.

SHENZHEN, China, November 7 /PRNewswire/ --

- Ultra low power AVR XMEGA - voted leading microprocessor

Atmel(R) Corporation (Nasdaq: ATML), received a leading product accolade in the prestigious Electronic Design News (EDN) China Innovation Awards 2008.

BRITISH COLUMBIA, Canada, November 7 /PRNewswire/ --

- Innovative Biotech Targets Another Large Well-Known Product and Continues Expansion of Antibody Therapeutics Pipeline -

InNexus Biotechnology Inc., (OTC Bulletin Board: IXSBF; TSX Venture: IXS; http://www.ixsbio.com), a drug development company commercializing the next generation of monoclonal antibodies based on its Dynamic Cross Linking (DXL(TM)) technology, announces the development of a new antibody product from its DXL(TM) platform technology, DXL1218 (EGFR), for the prospective treatment of colorectal cancer.